Gene · 4477
Papers2,399
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,399
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-iPAS: a novel dCAS13-based method for alternative polyadenylation interference. | Nucleic Acids Res | 2022 | 35191504 | PubTator, text mining | PubMed |
| Prion Protein: The Molecule of Many Forms and Faces. | Int J Mol Sci | 2022 | 35163156 | PubTator, text mining | PubMed |
| New Drosophila models to uncover the intrinsic and extrinsic factors that mediate the toxicity of the human prion protein. | Dis Model Mech | 2022 | 35142350 | PubTator, text mining | PubMed |
| Retraction: Pleiotropic role of Drosophila phosphoribosyl pyrophosphate synthetase in autophagy and lysosome homeostasis. | PLoS Genet | 2022 | 35120116 | PubTator, text mining | PubMed |
| Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers. | J Proteome Res | 2022 | 35114790 | PubTator, text mining | PubMed |
| Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial. | Am Heart J | 2022 | 35065922 | PubTator, text mining | PubMed |
| Prostate secretory protein 94 inhibits sterol binding and export by the mammalian CAP protein CRISP2 in a calcium-sensitive manner. | J Biol Chem | 2022 | 35063506 | PubTator, text mining | PubMed |
| Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities. | Int J Mol Sci | 2022 | 35054814 | PubTator, text mining | PubMed |
| Differential LysoTracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis. | Cells | 2022 | 35053350 | PubTator, text mining | PubMed |
| Population-based genetic effects for developmental stuttering. | HGG Adv | 2022 | 35047858 | PubTator, text mining | PubMed |
| Autoantibodies in Sjögren's syndrome and its classification criteria. | J Transl Autoimmun | 2022 | 35024595 | PubTator, text mining | PubMed |
| Tumor-Selective Biodegradation-Regulated Photothermal H2 S Donor for Redox Dyshomeostasis- and Glycolysis Disorder-Enhanced Theranostics. | Small | 2022 | 35023625 | PubTator, text mining | PubMed |
| Regulating peroxisome-ER contacts via the ACBD5-VAPB tether by FFAT motif phosphorylation and GSK3β. | J Cell Biol | 2022 | 35019937 | PubTator, text mining | PubMed |
| Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. | Nat Commun | 2022 | 35013146 | PubTator, text mining | PubMed |
| Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium. | Sci Rep | 2022 | 34997134 | PubTator, text mining | PubMed |
| Prediction of clinically significant prostate cancer using polygenic risk models in Asians. | Investig Clin Urol | 2022 | 34983122 | PubTator, text mining | PubMed |
| 5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia. | J Pathol | 2022 | 34928497 | PubTator, text mining | PubMed |
| Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems. | J Clin Transl Endocrinol | 2022 | 34917483 | PubTator, text mining | PubMed |
| Facile production of tagless membrane scaffold protein for nanodiscs. | Anal Biochem | 2022 | 34848201 | PubTator, text mining | PubMed |
| Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity. | Mol Oncol | 2022 | 34792282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4477/papers?page=15